|View printer-friendly version|
|February 11, 2002 4:09 p.m.|
|Teva Announces Tentative Approval for Quinapril HCl Tablets|
Jerusalem, Israel, February 11, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for Quinapril HCL 5, 10, 20 and 40 mg tablets. This is the first tentative approval granted by FDA for Quinapril.